Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Genialis

Genialis and Cleveland Clinic Collaborate to Develop AI-Powered Biomarkers that Improve Pancreatic Cancer Care
From Genialis
Via Business Wire
Genialis Highlights Power of Its Supermodel to Predict and Explain Therapeutic Response at AACR 2025
From Genialis
Via Business Wire
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
From Genialis
Via Business Wire
Genialis Launches First-in-Class Biomarker to Predict Tumor Response and Clinical Benefit to KRAS Inhibitors
From Genialis
Via Business Wire
Pharma Oncology Development Veteran Krista McKerracher Named Chairperson of the Board for Genialis
From Genialis
Via Business Wire
Genialis and Pancreatic Cancer Action Network (PanCAN) Partner to Progress KRAS Diagnostics
From Genialis
Via Business Wire
New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients
From Genialis
Via Business Wire
Genialis and Debiopharm Set Up Biomarker Discovery Collaboration
From Genialis
Via Business Wire
Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response
From Genialis
Via Business Wire
Clinical Drug Discovery Veterans Join Genialis’ Efforts to Build Better Biomarkers for Precision Oncology
From Genialis
Via Business Wire
Genialis Unveils Expressions Version 3.0, Cloud Software for Faster, More Secure Data Processing and Management
From Genialis
Via Business Wire
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
From Genialis
Via Business Wire
Genialis Presents New Clinical Biomarker Findings at SITC, BioTechX
From Genialis
Via Business Wire
Genialis Updates ResponderID, Enhancing Data Flywheel for Improved Clinical Biomarker Discovery
From Genialis
Via Business Wire
Genialis Releases Improved Version of Expressions for Faster, More Secure Multi-Omics Processing and Data Management
From Genialis
Via Business Wire
Genialis ResponderID to Use Xerna™ TME Panel to Improve Targeted Therapy Selection
From Genialis
Via Business Wire
Inhibrx Selects Genialis ResponderID™ for Clinical Optimization Study of INBRX-109
From Genialis
Via Business Wire
Genialis Debuts ResponderID for Clinical Biomarker Discovery
From Genialis
Via Business Wire
Genialis Innovates Machine Learning Solutions for Clinical Biomarker Discovery
From Genialis
Via Business Wire
Genialis Expands Support for Clinical Biomarker Discovery Platform
From Genialis
Via Business Wire
Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR
From Genialis
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.